Reversal of cylindrical bronchial dilatations in a subset of adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor
Background
This study sought to evaluate the impact of elexacaftor-tezacaftor-ivacaftor (ETI) on lung structural abnormalities in adults with cystic fibrosis (awCF) with a specific focus on the reversal of bronchial dilatations.
Methods
Chest computed tomography (CT) performed prior to, and ≥12 months after initiation of ETI were visually reviewed for possible reversal of bronchial dilatations. AwCF with and without reversal of bronchial dilatation (the latter served as controls with 3 controls per case) were selected. Visual Brody score, bronchial and arterial diameters, and lung volume were measured on CT.
Results
Reversal of bronchial dilatation was found in 12/235 (5%) awCF treated with ETI. Twelve awCF with and 36 without reversal of bronchial dilatations were further analyzed (male=56%, mean age=31.6±8.5 years,F508del/F508del CFTR=54% and mean %predicted forced expiratory volume in 1 s=58.8%±22.3). The mean±sdBrody score improved overall from 79.4±29.8 to 54.8±32.3 (p<0.001). Reversal of bronchial dilatations was confirmed by a decrease in bronchial lumen diameter in cases from 3.9±0.9 mm to 3.2±1.1 mm (p<0.001), whereas it increased in awCF without reversal of bronchial dilatation (from 3.5±1.1 mm to 3.6±1.2 mm, p=0.002). Reversal of bronchial dilatations occurred in cylindrical (not varicose or saccular) bronchial dilatations. Lung volumes decreased by −6.6±10.7% in awCF with reversal of bronchial dilatation but increased by +2.3±9.6% in controls (p=0.007).
Conclusion
Although bronchial dilatations are generally considered irreversible, ETI was associated with reversal, which was limited to the cylindrical bronchial dilatations subtype, and occurred in a small subset of awCF. Initiating ETI earlier in life may reverse early bronchial dilatations.
Топ-30
Журналы
|
1
2
3
4
|
|
|
European Respiratory Journal
4 публикации, 22.22%
|
|
|
American Journal of Respiratory and Critical Care Medicine
1 публикация, 5.56%
|
|
|
Nature Reviews Disease Primers
1 публикация, 5.56%
|
|
|
European Respiratory Review
1 публикация, 5.56%
|
|
|
Canadian Association of Radiologists Journal
1 публикация, 5.56%
|
|
|
Journal of Imaging
1 публикация, 5.56%
|
|
|
Molecular and Cellular Pediatrics
1 публикация, 5.56%
|
|
|
Therapeutic Advances in Respiratory Disease
1 публикация, 5.56%
|
|
|
BMC Pulmonary Medicine
1 публикация, 5.56%
|
|
|
ERJ Open Research
1 публикация, 5.56%
|
|
|
Diagnostic and interventional imaging
1 публикация, 5.56%
|
|
|
Medical radiology
1 публикация, 5.56%
|
|
|
Archivos de Bronconeumologia
1 публикация, 5.56%
|
|
|
The Lancet Respiratory Medicine
1 публикация, 5.56%
|
|
|
Radiology Cardiothoracic Imaging
1 публикация, 5.56%
|
|
|
1
2
3
4
|
Издатели
|
1
2
3
4
5
6
|
|
|
European Respiratory Society (ERS)
6 публикаций, 33.33%
|
|
|
Springer Nature
4 публикации, 22.22%
|
|
|
Elsevier
3 публикации, 16.67%
|
|
|
SAGE
2 публикации, 11.11%
|
|
|
American Thoracic Society
1 публикация, 5.56%
|
|
|
MDPI
1 публикация, 5.56%
|
|
|
Radiological Society of North America (RSNA)
1 публикация, 5.56%
|
|
|
1
2
3
4
5
6
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.